ReviewEuropean journal of clinical investigation2015

Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention.

Dimitrios C Mastellos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.